New England Patriots offensive tackle Nate Solder played the entire 2014 season after being diagnosed with testicular cancer. He survived it, after it was detected early on, just to have his family get another dose of crushing news.
He revealed that his 4-month-old son, Hudson, battling a rare form of kidney cance and has undergone chemotherapy to treat it.
Nate Solder made the announcement at a charity event this week for the Joe Andruzzi Foundation, according to ESPN. He and his wife reportedly wanted to draw attention to the rare cancer called a Wilms' tumor, which primarily affects young children under age 5.
Hudson has already undergone chemotherapy treatments at Boston Children’s Hospital, Nate revealed during the gala.
This is the second cancer diagnosis for Solder's family in the past two years. Solder revealed in April that he was treated for testicular cancer prior to the 2014 season. He said then that he hoped to use his platform as an NFL player to spread awareness.
He is currently sitting the season out due to a bicep injury that has left him on the reserve list.
Solder posted a picture on Twitter of his son Hudson being treated at the hospital to thank supporters.
He tweeted, “Thank you everyone ! support the #JAF -God is better than we can imagine.”
Support is pouring in for Hudson and his family. “Thought and prayers to Patriots T Nate Solder who revealed his infant son has kidney cancer and was undergoing chemo treatment,” ESPN on NFL tweeted out. We wish all the best to the Hudson and the Solder family during this difficult time.
Wilms' tumor is a rare kidney cancer that primarily affects children. Also known as nephroblastoma, Wilms' tumor is the most common cancer of the kidneys in children. Wilms' tumor most often affects children ages 3 to 4 and becomes much less common after age 5.
